Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman Sells 1,212 Shares

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 1,212 shares of the business’s stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $21.03, for a total value of $25,488.36. Following the completion of the transaction, the general counsel now owns 119,791 shares of the company’s stock, valued at $2,519,204.73. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Phreesia Trading Down 2.2 %

Shares of NYSE:PHR opened at $20.40 on Friday. The stock has a 50 day moving average of $23.36 and a 200 day moving average of $22.44. The company has a market cap of $1.17 billion, a PE ratio of -9.40 and a beta of 0.93. Phreesia, Inc. has a 12-month low of $12.05 and a 12-month high of $29.16. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.03.

Phreesia (NYSE:PHR) last posted its quarterly earnings results on Wednesday, September 4th. The company reported ($0.31) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.37) by $0.06. The business had revenue of $102.12 million during the quarter, compared to analyst estimates of $101.76 million. Phreesia had a negative net margin of 25.73% and a negative return on equity of 39.34%. As a group, equities research analysts expect that Phreesia, Inc. will post -1.23 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have commented on PHR shares. JPMorgan Chase & Co. lifted their target price on shares of Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, September 9th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $34.00 price objective on shares of Phreesia in a report on Thursday, September 5th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $23.00 target price on shares of Phreesia in a research report on Friday, September 27th. Finally, KeyCorp cut their price target on Phreesia from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, July 11th. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, Phreesia has an average rating of “Moderate Buy” and an average target price of $29.42.

Institutional Investors Weigh In On Phreesia

A number of institutional investors and hedge funds have recently bought and sold shares of PHR. Trust Point Inc. lifted its holdings in Phreesia by 3.5% in the 3rd quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after purchasing an additional 607 shares in the last quarter. Ensign Peak Advisors Inc lifted its holdings in shares of Phreesia by 3.2% in the second quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after buying an additional 700 shares in the last quarter. ProShare Advisors LLC boosted its stake in Phreesia by 8.6% during the first quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock valued at $228,000 after buying an additional 751 shares during the last quarter. Rhumbline Advisers grew its holdings in Phreesia by 1.0% during the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock valued at $1,741,000 after buying an additional 853 shares in the last quarter. Finally, Swiss National Bank raised its holdings in shares of Phreesia by 1.0% during the 1st quarter. Swiss National Bank now owns 104,300 shares of the company’s stock worth $2,496,000 after acquiring an additional 1,000 shares in the last quarter. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.